Several Reglan Products Recalled Due to Link with Dangerous Medical Condition
On February 26, 2009 the FDA issued a black box warning regarding the connection between tardive dyskinesia and Reglan use.
The specific Reglan products included in the recall were:
Reglan Tablets: Regan tablets come in 5 mg and 10 mg scored tablets. The mg amount refers to the amount of metoclopramide base in each tablet. Reglan tablets are FDA approved for adult use only and it is recommended that treatment be limited to a maximum of 12 weeks.
Reglan Oral Disintegrating Tablets: these tablets dissolve quickly in the mouth and do not need to be swallowed like the traditional raglan tablets. They do however contain the same active ingredients as other types of Reglan medications.
Metoclopramide Oral Solution: the oral solution of Reglan provides 5 mg of metoclopramide per teaspoon. This is often the form of Reglan provided to infants since it does not present the choking hazard that tablets can present.
Reglan Injection: Reglan can also be injected directly into a patient's vein or muscle. The dosage and frequency of the injections is determined by a patient's physician. Some doctors provide infants with raglan injections to be sure that the medication is getting into the body and is not spit out by the baby.
All Reglan Products are Potentially Dangerous
While Reglan is available in the different products listed above, it is important to consider what all of these products have in common. Specifically,
- They all contain metoclopramide;
- None of them have been approved for use in infants or children;
- They can all potentially lead to tardive dyskinesia. Tardive dyskinesia causes patients to move involuntarily and is very rarely reversible.
If your child has developed tardive dyskinesia and taken a Reglan product then it is important to contact a Reglan attorney for help.
